C. Moiteiro et al. / Tetrahedron: Asymmetry 17 (2006) 3248–3264
3261
1
1419, 994, 914; H NMR (CDCl3): d 1.26 (3H, s, CH3-20),
intensity, %): 637 [M+2]+ (1.2), 635 [M]+ (28.1), 619
(25.9), 617 [MꢁH2O]+ (33.6), 601 (30.0), 541 [Mꢁ
HSi(CH3)2Cl]+ (22.2), 525 [Mꢁ(OH+Si(CH3)2Cl)]+
(89.3), 508 (14.6), 329 (6.6), 328 (13.1), 312 (9.4), 289
(1.5), 263 (19.6), 262 (40.4), 247 (26.0), 93 (100), 83
(23.6), 69 (46.8), 55 (60.9), 43 [CH(CH3)2]+ (40.5), 41
(32.8).
1.32 (6H, d, J = 6.9 Hz, CH3-16 and 17), 1.39 (3H, s, CH3-
19), 1.54 (2H, m, H-1ax and H-6ax), 1.88 (5H, m, 2H-2, 2H-
3, H-6eq), 2.26 (1H, br d, J = 13.6 Hz, H-1eq), 2.30 (1H, dl,
J = 12.1 Hz, H-5), 2.82 (2H, m, 2H-7), 3.03 (1H, hept,
J = 6.9 Hz, H-15), 7.54 (1H, s, H-11); EIMS m/z (relative
intensity, %): 410 [M+2]+ (1.8), 408 [M]+ (4.9), 393
[MꢁCH3]+ (14.7), 391 [MꢁOH]+ (36.5), 329 [Mꢁ(CO+
HCl)]+ (55.7), 263 (45.4), 43 [CH(CH3)2]+ (100).
4.4.4. Chemically bonded CSP 2. The covalent linkage of
chiral selector 9 to silica gel was carried out following a
similar procedure described above for CSP 1. Elemental
analysis of CSP 2 (found: C, 14.26; H, 2.30; N, 1.29) gave
a loading of 0.36 mmol of selector (based on C) or
0.31 mmol (based on N) per gram of stationary phase.
The bonded phase was slurried in methanol and packed
in a 150 · 4.6 mm ID stainless steel HPLC column using
a conventional slurry packing method. Endcapping of
modified silica was carried out using the procedure detailed
in Section 4.3.5.
4.4.2. N-(100-Undecenyl)-12,14-dinitrodehydroabietamide,
8. Compound 8, prepared following the procedure de-
scribed in Section 4.3.3 was obtained as a yellow oil in an
23
86% yield; ½aꢂD ¼ þ36:9 (c 1, acetone); IR (NaCl cell,
cmꢁ1): 3367 (NH), 3075, 2927, 2855, 1631 (C@O), 1536
1
(NO), 1466, 1365 (NO), 961, 750, 735; H NMR (CDCl3):
d 1.24 (3H, s, CH3-20), 1.26 (3H, s, CH3-19), 1.28 (12H, s,
H-30–80), 1.31 (6H, d, J = 6.9 Hz, CH3-16 and 17), 1.53
(5H, m, H-1ax, 2H-6 and 2H-20), 1.76 (4H, m, 2H-2 and
2H-3), 2.03 (2H, q, J = 6.9 Hz, H-90), 2.23 (2 H, m, H-1eq
and H-5), 2.85 (2H, m, 2H-7), 3.02 (1H, hept, J =
6.9 Hz, H-15), 3.26 (2H, q, J = 7.2 Hz, H-10), 4.88
4.5. Synthesis of CSP 3
0
0
ð1H; br d; J11 ;10 ðcisÞ ¼ 10:2 Hz, HCH@CH), 4.90 (1H, dd,
4.5.1. 40-(Chlorocarbonyl)-10-friedelan-3a-yl-benzoate, 10.
Friedelan-3a-ol 3a (0.28 g, 0.65 mmol) dissolved in dry
toluene (25 mL) was added to tereftaloyl chloride
(0.599 g, 2.97 mmol) and 4-dimethylaminepyridine (4-
DMAP) (0.125 g, 1.03 mmol) and then the mixture was
heated under reflux for 8 h. The toluene was removed
under reduced pressure and the residue was used in the
next reaction without purification.
0
0
J11 ;10 ðtransÞ ¼ 17:1 and Jgem = 1.5 Hz, HCH@CH), 5.82
(2H, m, H-100 and NH, D2O exchange), 7.54 (1H, s, H-
11); 13C NMR (CDCl3): d 37.64 (C-1), 18.32 (C-2), 36.74
(C-3), 46.73 (C-4), 43.54 (C-5), 20.54 (C-6), 24.50 (C-7),
130.62 (C-8), 151.03 (C-9), 37.52 (C-10), 121.21 (C-11),
149.24 (C-12), 139.02 (C-13), 151.87 (C-14), 33.77 (C-15),
20.61 (C-16), 20.64 (C-17), 177.20 (C-18, C@O amide),
16.56 (C-19), 24.90 (C-20), 39.92 (C-10), 29.57, 29.46,
29.37, 29.23, 29.06, 28.95, (7C, C-20 to C-80 of aliphatic
chain), 26.94 (C-90), 139.02 (C-100), 113.99 (C-110); EIMS
m/z (relative intensity, %): 541 [M]+ (19.0), 526 [MꢁCH3]+
(54.3), 524 [MꢁOH]+ (37.8), 329 [Mꢁ(CONH2(CH2)9-
CHCH2+CH3)]+ (19.4), 313 (7.6), 289 (1.7), 275 (13.0),
263 (49.1), 249 (4.8), 238 (24.5), 224 (9.6), 55 (100), 43 [CH-
(CH3)2]+ (72.4), 41 (75.7); HRMS(EI) m/z: 540.343898
[MꢁH]ꢁ (calculated for C31H46N3O5 540.344296).
4.5.2. 40-(N-1000-Undecenylamide)-10-friedelan-3a-yl-benzo-
ate, 11. 10-Undecenylamine (0.133 g, 0.79 mmol) in
5 mL ether was added to a solution of 10 in dry pyridine
(0.5 mL) at 0 ꢁC and the mixture was stirred at room
temperature for 2 h. The solvent was evaporated under
reduced pressure and the white crude product obtained
was purified by column chromatography on silica gel using
dichloromethane/methanol (1%) as the eluent affording
0.211 g of 11 in
a
45% yield. Mp 218–220 ꢁC;
23
4.4.3. N-[110-(Chlorodimethylsilyl)undecyl]-12,14-dinitrode-
hydroabietamide, 9. Compound 9, prepared using the
procedure described in Section 4.3.4 was isolated as a yel-
low oil in a quantitative yield; IR (NaCl cell, cmꢁ1): 3300
(NH), 3075, 2926, 2855, 1631 (CO), 1536 (NO), 1467,
1368 (NO), 1255 (Si–C), 1059 (Si–O–C), 909, 840 (Si–O),
½aꢂD ¼ ꢁ6:4 (c 0.94, CH2Cl2); IR (KBr, cmꢁ1): 3402
(NH), 2926, 2855, 2870, 1715 (C@O ester), 1642 (C@C
and C@O amide), 1545, 1437, 1278; H NMR (CDCl3): d
1
0.83 (3H, d, J = 6.3 Hz, CH3-23), 0.85 (3H, s, CH3-24),
0.89 (3H, s, CH3-25), 0.96 (3H, s, CH3-30), 1.01 (6H, s,
CH3-27 and CH3-29), 1.03 (3H, s, CH3-26), 1.17 (3H, s,
CH3-28), 1.28 (14H, s, H-200 to H-800), 2.04 (2H, dt,
J = 6.5 and 7.3 Hz, H-900), 2.23 (1H, m, H-4), 3.47 (2H,
q, J = 6.7 Hz, H-100), 4.96 (3H, m, H-3 and 2H-1100), 5.84
(1H, m, H-1000), 6.29 (1H, t, J = 5.1 Hz, NH, D2O ex-
change), 7.82 (2H, d, J=8.1 Hz, Ar–H-30 and Ar–H-50),
8.07 (2H, d, J = 8.1 Hz, Ar–H-20 and Ar–H-60); 13C
NMR (CDCl3): d 19.31 (C-1), 32.62 (C-2), 76.40 (C-3),
50.10 (C-4), 38.25 (C-5), 41.28 (C-6), 17.8 (C-7), 52.96
(C-8), 36.97 (C-9), 59.85 (C-10), 35.51 (C-11), 30.51
(C-12), 39.62 (C-13), 38.45 (C-14), 32.75 (C-15), 35.98
(C-16), 29.95, (C-17), 42.75 (C-18), 35.27 (C-19), 28.12
(C-20), 32.29 (C-21), 39.19 (C-22), 10.10 (C-23), 14.50
(C-24), 18.1 (C-25), 18.60 (C-26), 20.10 (C-27), 32.05 (C-28),
31.74 (C-29), 34.96 (C-30), 133.32 (C-10), 126.77 (C-20),
129.65 (C-30), 138.47 (C-40), 129.65 (C-50), 126.77 (C-60),
40.20 (C-100), 29.56, 29.42, 29.33, 29.23, 29.03, 28.84 (C-
1
799 (Si–C), 735; H NMR (CDCl3): d 0.40 (6H, br s, Si–
(CH3)2), 0.83 (2H, m, H-110), 1.29 (3H, s, CH3-19), 1.27
(12H, s, H-30–80), 1.24 (3H, s, CH3-20), 1.30 (6H, d,
J = 7.2 Hz, CH3-16 and 17), 1.56 (5H, m, H-1ax, 2H-6
and H-20), 1.78 (4H, m, 2H-2 and 2H-3), 2.24 (2 H, m,
H-1eq and H-5), 2.75 (2H, m, 2H-7), 3.01 (1H, hept,
J = 6.9 Hz, H-15), 3.22 (2H, q, J = 7.2 Hz, H-10), 6.04
(1H, br s, NH, D2O exchange), 7.55 (1H, s, H-11); 13C
NMR (CDCl3): d 37.63 (C-1), 18.28 (C-2), 36.59 (C-3),
46.76 (C-4), 43.47 (C-5), 19.53 (C-6), 24.47 (C-7), 130.63
(C-8), 151.04 (C-9), 37.42 (C-10), 121.30 (C-11), 149.35
(C-12), 128.33 (C-13), 151.96 (C-14), 32.91 (C-15), 20.62
(C-16), 20.53 (C-17), 177.60 (C-18, C@O amide), 16.58
(C-19), 24.88 (C-20), 40.14 (C-10), 29.50, 29.43, 29.22,
28.94, 26.91 (7C of aliphatic chain, C-20 to C-80), 22.93,
(C-100), 18.94 (C-110), 1.65 (CH3–Si); EIMS m/z (relative